Woodard & Company Asset Management Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.3M | Buy |
12,226
+529
| +5% | +$189K | 0.69% | 33 |
|
|
2025
Q4 | $3.83M | Buy |
11,697
+1,154
| +11% | +$366K | 0.61% | 32 |
|
|
2025
Q3 | $2.98M | Buy |
10,543
+735
| +7% | +$213K | 0.48% | 35 |
|
|
2025
Q2 | $2.74M | Buy |
9,808
+471
| +5% | +$133K | 0.5% | 35 |
|
|
2025
Q1 | $2.91M | Sell |
9,337
-1,157
| -11% | -$342K | 0.61% | 30 |
|
|
2024
Q4 | $2.74M | Buy |
10,494
+222
| +2% | +$65.9K | 0.59% | 29 |
|
|
2024
Q3 | $3.31M | Buy |
10,272
+138
| +1% | +$45.1K | 0.74% | 29 |
|
|
2024
Q2 | $3.17M | Sell |
10,134
-37
| -0.4% | -$10.9K | 0.79% | 21 |
|
|
2024
Q1 | $2.89M | Buy |
10,171
+650
| +7% | +$190K | 0.77% | 27 |
|
|
2023
Q4 | $2.74M | Sell |
9,521
-753
| -7% | -$205K | 0.8% | 22 |
|
|
2023
Q3 | $2.76M | Sell |
10,274
-71
| -0.7% | -$17.7K | 0.94% | 20 |
|
|
2023
Q2 | $2.3M | Buy |
10,345
+342
| +3% | +$79.4K | 0.76% | 26 |
|
|
2023
Q1 | $2.42M | Buy |
10,003
+205
| +2% | +$50.3K | 0.84% | 24 |
|
|
2022
Q4 | $2.57M | Buy |
9,798
+258
| +3% | +$69.2K | 0.91% | 19 |
|
|
2022
Q3 | $2.15M | Buy |
9,540
+770
| +9% | +$187K | 0.99% | 16 |
|
|
2022
Q2 | $2.13M | Sell |
8,770
-308
| -3% | -$75.5K | 0.88% | 18 |
|
|
2022
Q1 | $2.19M | Sell |
9,078
-221
| -2% | -$50.8K | 0.92% | 19 |
|
|
2021
Q4 | $2.09M | Buy |
9,299
+844
| +10% | +$178K | 0.99% | 18 |
|
|
2021
Q3 | $1.8M | Buy |
8,455
+183
| +2% | +$42.1K | 1.11% | 17 |
|
|
2021
Q2 | $2.02M | Buy |
8,272
+1,213
| +17% | +$298K | 1.21% | 17 |
|
|
2021
Q1 | $1.76M | Buy |
7,059
+225
| +3% | +$53.7K | 1.12% | 19 |
|
|
2020
Q4 | $1.57M | Buy |
6,834
+359
| +6% | +$82.8K | 0.96% | 16 |
|
|
2020
Q3 | $1.65M | Buy |
6,475
+36
| +0.6% | +$8.92K | 1.08% | 15 |
|
|
2020
Q2 | $1.52M | Buy |
6,439
+287
| +5% | +$65.5K | 1.03% | 13 |
|
|
2020
Q1 | $1.25M | Buy |
6,152
+478
| +8% | +$104K | 0.9% | 14 |
|
|
2019
Q4 | $1.37M | Buy |
5,674
+356
| +7% | +$78.5K | 0.82% | 16 |
|
|
2019
Q3 | $1.03M | Buy |
+5,318
| New | +$1.02M | 0.65% | 18 |
|
|
2018
Q4 | – | Sell |
-4,684
| Closed | -$970K | – | 33 |
|
|
2018
Q3 | $970K | Buy |
4,684
+125
| +3% | +$24.6K | 0.88% | 10 |
|
|
2018
Q2 | $842K | Buy |
4,559
+10
| +0.2% | +$1.77K | 0.82% | 11 |
|
|
2018
Q1 | $781K | Buy |
4,549
+415
| +10% | +$76.2K | 0.76% | 15 |
|
|
2017
Q4 | $714K | Buy |
+4,134
| New | +$732K | 0.62% | 20 |
|
Other funds holding AMGN
VCM
VPM
Woodard & Company Asset Management Group's AMGN Position: Q1 2026 in Review
Woodard & Company Asset Management Group increased its Amgen (AMGN) stake by 4.5% in Q1 2026, buying an estimated $189K and bringing the position to 12,226 shares worth $4.3M. The position accounts for 0.69% of the portfolio, ranked #33.
Woodard & Company Asset Management Group first reported a position in AMGN in Q4 2017 and has held it in 31 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- Woodard & Company Asset Management Group held 12,226 shares of Amgen worth $4.3M as of Q1 2026.
- Woodard & Company Asset Management Group bought 529 Amgen shares in Q1 2026, an estimated $189K.
- Amgen made up 0.69% of Woodard & Company Asset Management Group's portfolio in Q1 2026, its #33 holding.
- Woodard & Company Asset Management Group first reported a position in Amgen in Q4 2017 and has held it in 31 quarters since.
- 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on Woodard & Company Asset Management Group's 13F filing for Q1 2026, filed 28 Apr 2026.